Delivery Order SPE2DB20D3303-SPE2DB24FZ9H7

Award Date 6/6/24
Potential Completion Date 6/7/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The $3,300.17 firm fixed price contract is for the supply of Clonidine Hydrochloride Extended-Release 0.1 mg tablets in 60-count bottles. The contract has an ultimate completion date of July 22, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,006.82 firm fixed price delivery order is for the supply of Clonidine Hydrochloride Extended Release 0.17 mg Tablets in 30-count packages. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $4,806.91 firm fixed-price contract is for the provision of clonidine hydrochloride extended-release 0.1 mg tablets. The award is not associated with a set-aside program. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle for...
This federal contract award, valued at $1,078.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of clonidine hydrochloride extended-release 0.17 mg tablets in 30-count packages. The contract has an ultimate completion date of May 8, 2024 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp, a subsidiary of the larger Amerisourcebergen Corporation, is a major supplier of pharmaceutical...
This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, valued at $2,871.68, is for the supply of Clonidine HCL ER 0.1 mg tablets in 60-count packages. The contract does not have a set-aside designation and has a completion date of September 5, 2024. Amerisourcebergen is a major pharmaceutical distributor that supplies a wide range of essential medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of clonidine HCL ER 0.1 mg tablets in 60-count packages. The $20,024.68 firm fixed-price contract has a completion date of March 12, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, serving as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Clonidine Hydrochloride Extended-Release 0.1 mg tablets. The contract is a Firm Fixed Price Delivery Order valued at $2,027.41, with an ultimate completion date of October 16, 2024. No set-aside designation was used for this award. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,400.26, is for the delivery of clonidine hydrochloride extended-release 0.1 mg tablets. The contract has an ultimate completion date of January 29, 2025 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $2,489.45. The contract is for the delivery of clonidine hydrochloride extended-release 0.1 mg tablets in 60-count packages. The contract has an ultimate completion date of March 3, 2025 and was awarded on February 28, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $2,139.57 firm-fixed-price delivery order is for the supply of clonidine hydrochloride extended-release 0.1 milligram tablets. The contract has an ultimate completion date of August 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FZ9H7
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of Clonidine Hydrochloride Extended Release 0.17 mg Tablets in quantities of 30. The contract has a firm fixed price of $1,257.88 and a completion date of June 7, 2024.

Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The company holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical and medical products to DLA facilities supporting the DoD worldwide. This specific delivery order contract is not designated as a set-aside.

Generated 9/5/24, 9:18 AM